Recipient-derived allo-iTregs induced by donor DCs effectively inhibit the proliferation of donor T cells and reduce GVHD.

08:00 EDT 12th October 2018 | BioPortfolio

Summary of "Recipient-derived allo-iTregs induced by donor DCs effectively inhibit the proliferation of donor T cells and reduce GVHD."

To compare the potency of recipient-derived, antigen-specific regulatory T cells induced by different dendritic cells (DCs) (iTregs) and freshly isolated natural regulatory T cells (nTregs) in preventing mouse graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT).


Journal Details

This article was published in the following journal.

Name: Anatomical record (Hoboken, N.J. : 2007)
ISSN: 1932-8494


DeepDyve research library

PubMed Articles [18787 Associated PubMed Articles listed on BioPortfolio]

TIGIT iTregs elicited by human regulatory macrophages control T cell immunity.

Human regulatory macrophages (Mreg) have shown early clinical promise as a cell-based adjunct immunosuppressive therapy in solid organ transplantation. It is hypothesised that recipient CD4 T cell res...

Quantifying the effect of transplanting older donor livers into younger recipients: the need for donor-recipient age matching.

Increasing recipient and donor age are independently associated with survival after liver transplantation (LT). Whether donor age differentially impacts post-LT outcomes based on recipient age is unkn...

Donor T-cell-derived interleukin-22 promotes thymus regeneration and alleviates chronic graft-versus-host disease in murine allogeneic hematopoietic cell transplant.

Defect of thymus results in poor posttransplant immune recovery and dysfunction of immune tolerance after allogeneic hematopoietic cell transplants (allo-HCT). Improving thymus regeneration represents...

Recipient-derived IL-22 alleviates murine acute graft-versus-host disease in association with reduced activation of antigen presenting cells.

Acute graft-versus-host disease (aGVHD) remains a major challenging complication of patients receiving allogeneic hematopoietic cell transplantation (allo-HCT). CD4 effector T cells and their related ...

Association of recipient and donor hypercholesterolemia prior allogeneic stem cell transplantation and graft-versus-host disease.

Few authors have reported a decreased frequency of acute graft-versus-host disease (aGVHD) using statins, as these medications have anti-inflammatory effects, however, to date, the direct association ...

Clinical Trials [6339 Associated Clinical Trials listed on BioPortfolio]

A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory Leukemia

Allogenic hematopoietic stem cell transplant (Allo-HSCT) is routinely used for treatment of aggressive hematological malignancies. The biological foundation of allo-HSCT is the graft-versu...

MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT

Allogeneic stem cell transplantation (allo-SCT) is a potent treatment, and sometimes the only curative treatment for aggressive hematological malignancies. The therapeutic efficacy is attr...

Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is a curative option for patients with acute myeloid leukemia (AML). However, transplantation related toxicity and mortality ...

Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

Donor: This clinical study will evaluate the feasibility of a purified CD34 peripheral blood progenitor cell (PBPC) transplants in patients with hematological malignancies. The pri...

Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes

Objectives: 1. Determine the toxicity of infusions of allogeneic donor lymphocytes activated by acute leukemia derived dendritic cells (DC/ADL) in relapsed patients after allo-stem...

Medical and Biotech [MESH] Definitions

A mismatch between donor and recipient blood. Antibodies present in the recipient's serum are directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)

The transfer of leukocytes from a donor to a recipient or reinfusion to the donor.

The transfer of lymphocytes from a donor to a recipient or reinfusion to the donor.

The transfer of erythrocytes from a donor to a recipient or reinfusion to the donor.

The transfer of blood platelets from a donor to a recipient or reinfusion to the donor.

Quick Search


DeepDyve research library

Relevant Topics

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Searches Linking to this Article